This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

Peter Rudd-Clarke

Peter Rudd-Clarke

Partner, Osborne Clarke

Articles

Is the UK’s life sciences regulator, the MHRA, creating the right conditions to encourage businesses investing in artificial intelligence products?

Is the UK’s life sciences regulator, the MHRA, creating the right conditions to encourage businesses investing in artificial intelligence products?

Peter Rudd-Clarke, a Partner in Osborne Clarke’s life sciences and healthcare team, Tamara Quinn, a Director in Osborne Clarke’s AI, data and IP knowledge team, and Julia Smith, an associate in Osborne Clarke’s commercial team, provide a detailed breakdown of the approach being taken to artificial intelligence within the life sciences sector and the upcoming regulatory developments